arXiv subjects

Peter Gray

Publications and source records attributed to Peter Gray.

3 recordsLinked to original sources

arXiv2026

The final design of GMagAO-X: high-contrast imaging at first-light of the GMT

GMagAO-X will be the first-light high-contrast imager on the 25 m Giant Magellan Telescope. The driving science case for GMagAO-X is characterization of the atmospheres of nearby rocky exoplanets such as Proxima Centauri b. The revolutionary increase in spatial resolution and sensitivity provided by GMagAO-X will enable detailed study of such planets for the first time. Additional science cases include: reflected light characterization of mature giant planets; measurement of young extrasolar giant planet variability; characterization of circumstellar disks at unprecedented spatial resolution; characterization of benchmark stellar atmospheres at high spectral resolution; and mapping of resolved objects such as giant stars and asteroids. These, and many more, science cases will be enabled by a 21,000 actuator extreme adaptive optics (ExAO) system, an integrated coronagraphic wavefront control system with dedicated deformable mirrors, and a suite of imagers and spectrographs. Science-driven performance requirements for GMagAO-X include achieving a Strehl ratio of 70% at 800 nm on 8th mag and brighter stars, and exoplanet characterization at planet:star flux-ratios of 1e-7 at 4 lambda/D (26 mas at 800 nm) separation. GMagAO-X has been added to the GMT project baseline plan and is in the final design phase, aiming to complete FDR in March, 2027. The instrument is on track to be ready at first-light of the GMT in the mid 2030s. We provide a brief update of the instrument designed to achieve our ambitious performance targets.

astro-ph.IM↗

arXiv2025

Apple Intelligence Foundation Language Models: Tech Report 2025

We introduce two multilingual, multimodal foundation language models that power Apple Intelligence features across Apple devices and services: i a 3B-parameter on-device model optimized for Apple silicon through architectural innovations such as KV-cache sharing and 2-bit quantization-aware training; and ii a scalable server model built on a novel Parallel-Track Mixture-of-Experts PT-MoE transformer that combines track parallelism, mixture-of-experts sparse computation, and interleaved global-local attention to deliver high quality with competitive cost on Apple's Private Cloud Compute platform. Both models are trained on large-scale multilingual and multimodal datasets sourced via responsible web crawling, licensed corpora, and high-quality synthetic data, then further refined with supervised fine-tuning and reinforcement learning on a new asynchronous platform. The resulting models support several additional languages while understanding images and executing tool calls. In public benchmarks and human evaluations, both the server model and the on-device model match or surpass comparably sized open baselines. A new Swift-centric Foundation Models framework exposes guided generation, constrained tool calling, and LoRA adapter fine-tuning, allowing developers to integrate these capabilities with a few lines of code. The latest advancements in Apple Intelligence models are grounded in our Responsible AI approach with safeguards like content filtering and locale-specific evaluation, as well as our commitment to protecting our users' privacy with innovations like Private Cloud Compute.

cs.LG↗

arXiv2011

A simple mathematical model for assessment of anti-toxin antibodies

The toxins associated with infectious diseases are potential targets for inhibitors which have the potential for prophylactic or therapeutic use. Many antibodies have been generated for this purpose, and the objective of this study was to develop a simple mathematical model that may be used to evaluate the potential protective effect of antibodies. This model was used to evaluate the contributions of antibody affinity and concentration to reducing antibody-receptor complex formation and internalization. The model also enables prediction of the antibody kinetic constants and concentration required to provide a specified degree of protection. We hope that this model, once validated experimentally, will be a useful tool for in vitro selection of potentially protective antibodies for progression to in vivo evaluation.

q-bio.QM↗